Antimicrobial Susceptibility Testing Market growing with a CAGR of 5.9%,size,Industry trends

Antimicrobial susceptibility testing market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 5.9% in the forecast period of 2022 to 2029 and is expected to reach USD 5,688.50 million by 2029 from USD 3,616.78 million in 2021. The high prevalence of infectious diseases and increasing awareness towards early diagnosis is the major driver which is propelling the market in the forecast period.

View Detailed Report: https://www.databridgemarketresearch.com/reports/global-antimicrobial-susceptibility-testing-market

Antimicrobial susceptibility testing (AST) is a laboratory procedure which is used to determine which antimicrobial impedes the growth of bacteria, fungi, and other microorganism causing a specific infection. Susceptibility testing is performed on microorganisms such as bacteria, fungi causing the infection after they have been recovered in a culture of the specimen.

Antibacterial drugs are playing the important role in the prevention of infectious diseases, however, the cases of drug misuse and overuse, led to the development of drug resistance. Delay in diagnosing the harmful microbes makes it difficult to control the spread of infectious diseases. This is putting pressure on the key players to manufacture the test kits which gives accurate and effective results to better treat the patients.

Testing is used to determine the potential effectiveness of antibiotics on microorganisms and determine if the microorganisms have developed resistance to certain antibiotics. The results of this test can help healthcare professionals to get access to better clinical diagnosis and select the drug that is most likely to be effective in treating that particular infection.

The major companies which are dealing in the antimicrobial susceptibility testing market are BD, Synbiosis, Zhuhai DL Biotech Co., Ltd, Mast Group Ltd., HiMedia Laboratories, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Creative Diagnostics, Genefluidics, Inc.,  Rosco Diagnostica A/S, ERBA Group, Liofilchem S.r.l., Alifax S.r.l., MERLIN Gesellschaft für mikrobiologische Diagnostika mbH, bioMérieux SA, Merck KGaA, Danaher, Accelerate Diagnostics, Inc., NuMedii, Inc., and BacterioScan, Inc. among others.among other domestic and Asia-Pacific players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separatelyMany product launch and agreement are also initiated by the companies' worldwide which are also accelerating the antimicrobial susceptibility testing market.

Antimicrobial Susceptibility Testing Market Scope and Market Size

Global antimicrobial susceptibility testing market is categorized into six notable segments which are based on product type, methods, type, application, end user and distribution channel.

On the basis of product type, antimicrobial susceptibility testing market is segmented into instruments, consumables & accessories and services & software. In 2022, instruments segment is expected to dominate the market as most companies are launching instruments for antimicrobial susceptibility testing.

On the basis of methods, antimicrobial susceptibility testing market is segmented into mass spectrometry method, dilution, disk diffusion, e-test, genotypic methods, and others. In 2022, disk diffusion method is expected to dominate as this method provides the accurate, reliable, and efficient results.

On the basis of type, antimicrobial susceptibility testing market is segmented into antibacterial testing, antifungal testing and others. In 2022, antibacterial testing segment is expected to dominate the market due to wide number of tests for antibacterial testing available in the market.

North America is expected to dominate the market due to the rising investments in development of novel methods for testing. U.S is dominating in North America market due rise in epidemic and pandemic events and presence of sophisticated healthcare infrastructure. Europe is expected to grow with the third highest growth rate in the forecast period of 2022 to 2029 due to increasing demand of fitness and health tracking devices in the region. 

Explore More Reports:

https://databridgemarketresearchreports.blogspot.com/2024/06/us-social-determinants-of-health-sdoh.html

https://databridgemarketresearchreports.blogspot.com/2024/06/kidney-disease-market-would-grow-up-to.html

https://databridgemarketresearchreports.blogspot.com/2024/06/osteoporosis-drug-market-to-reach-usd_20.html

https://databridgemarketresearchreports.blogspot.com/2024/06/inorganic-scintillators-market-would.html

About Data Bridge Market Research:

An absolute way to predict what the future holds is to understand the current trend! Data Bridge Market Research presented itself as an unconventional and neoteric market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are committed to uncovering the best market opportunities and nurturing effective information for your business to thrive in the marketplace. Data Bridge strives to provide appropriate solutions to complex business challenges and initiates an effortless decision-making process. Data Bridge is a set of pure wisdom and experience that was formulated and framed in 2015 in Pune.

Data Bridge Market Research has more than 500 analysts working in different industries. We have served more than 40% of the Fortune 500 companies globally and have a network of more than 5,000 clients worldwide. Data Bridge is an expert in creating satisfied customers who trust our services and trust our hard work with certainty. We are pleased with our glorious 99.9% customer satisfaction rating.

Contact Us: -
Data Bridge Market Research
US: +1 614 591 3140
United Kingdom: +44 845 154 9652
APAC: +653 1251 975
Email: - sopan.gedam@databridgemarketresearch.com

This release was published on openPR.